BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21952203)

  • 1. Remote-conditioning ischemia provides a potential approach to mitigate contrast medium-induced reduction in kidney function: a retrospective observational cohort study.
    Whittaker P; Przyklenk K
    Cardiology; 2011; 119(3):145-50. PubMed ID: 21952203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty.
    Zhao JL; Yang YJ; Zhang YH; You SJ; Wu YJ; Gao RL
    Int J Cardiol; 2008 Jun; 126(3):435-6. PubMed ID: 17462753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).
    Er F; Nia AM; Dopp H; Hellmich M; Dahlem KM; Caglayan E; Kubacki T; Benzing T; Erdmann E; Burst V; Gassanov N
    Circulation; 2012 Jul; 126(3):296-303. PubMed ID: 22735306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
    Li XM; Cong HL; Li TT; He LJ; Zhou YJ
    Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effect of remote ischemic post-conditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention.
    Deftereos S; Giannopoulos G; Tzalamouras V; Raisakis K; Kossyvakis C; Kaoukis A; Panagopoulou V; Karageorgiou S; Avramides D; Toutouzas K; Hahalis G; Pyrgakis V; Manolis AS; Alexopoulos D; Stefanadis C; Cleman MW
    J Am Coll Cardiol; 2013 May; 61(19):1949-55. PubMed ID: 23500314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does estimated glomerular filtration rate have an effect on left ventricular function after ST-elevation myocardial infarction?
    Sonmez O; Vatankulu MA; Tasal A; Bacaksiz A; Ayhan S; Yazici HU; Karakaya E; Ozdogru I; Aygul N; Ozdemir K; Abaci A
    Echocardiography; 2014 Mar; 31(3):318-24. PubMed ID: 24103085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More contrast, no more brightness.
    Tortoledo F
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):344-5. PubMed ID: 12822154
    [No Abstract]   [Full Text] [Related]  

  • 19. Remote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization? justification and design of a randomized placebo-controlled clinical trial.
    Jiménez-Navarro MF; Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Caballero-Borrego J; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E
    Cardiology; 2011; 119(3):164-9. PubMed ID: 21952349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study.
    Laskey WK
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):361-7. PubMed ID: 15945105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.